The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE

Background: This study aimed to estimate the levels of CRP and PRL in SARS-CoV2 infection and their association with the severity of COVID-19 among patients in Ajman, UAE. Methods and Results: This cross-sectional study was conducted in Thumpay Hospital from 2020 to 2021. The study included 71 pat...

Full description

Bibliographic Details
Main Authors: Aisha Abdulkrim Nur, Ahmed L. Osman, Praveen Kumar Kandakurti, Ayman H. Alfeel, Marwan Ismail, Asaad Ma. Babker, Abdelgdair A. Altoum
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2023-12-01
Series:International Journal of Biomedicine
Subjects:
Online Access:http://www.ijbm.org/articles/i52/ijbm_13(4)_oa9.pdf
_version_ 1797399247738372096
author Aisha Abdulkrim Nur
Ahmed L. Osman
Praveen Kumar Kandakurti
Ayman H. Alfeel
Marwan Ismail
Asaad Ma. Babker
Abdelgdair A. Altoum
author_facet Aisha Abdulkrim Nur
Ahmed L. Osman
Praveen Kumar Kandakurti
Ayman H. Alfeel
Marwan Ismail
Asaad Ma. Babker
Abdelgdair A. Altoum
author_sort Aisha Abdulkrim Nur
collection DOAJ
description Background: This study aimed to estimate the levels of CRP and PRL in SARS-CoV2 infection and their association with the severity of COVID-19 among patients in Ajman, UAE. Methods and Results: This cross-sectional study was conducted in Thumpay Hospital from 2020 to 2021. The study included 71 patients (55 males and 16 females) with positive SARS-CoV-2 test results. Nasal swab specimens were collected for the COVID-19 test on the day of admission or after one day of admission. COVID-19 diagnoses and severity levels were determined according to the New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China (2020). Serum samples were collected from the patients upon admission. The PRL level was determined using the immune chemiluminescent method by the DXI 800 Beckman Coulter analyzer. The CRP level was determined using the immunoturbidimetric method by the DXC 700 AU chemistry analyzer. Among 71 COVID-19 patients, the great majority were men 55(77.5%), 38(53.5%) being of Indian nationality. In this study, most participants (50.7%) had no history of chronic illnesses. In terms of COVID-19 severity, 24(33.8%) of patients had mild cases, 27(38.0%) had moderate cases, and 20(28.2%) had severe cases. Twenty (28.2%) patients were transferred to the ICU, and 19(26.8%) were intubated. The patients' average age was 47.58±13.63, CRP level - 74.30±71.46 mg/L, and PRL level - 205.1946±168.52 ng/mL. The mean CRP level was highest in severe cases, compared to mild and moderate cases, with a statistically significant difference between mild and severe groups (P=0.000) and mild and moderate groups (P=0.004). The mean PRL level was highest in severe cases compared to mild and moderate cases; however, the differences between the groups were not significant. CRP and PRL levels were greater in the ICU patients than non-ICU patients, with statistically significant differences only for CRP. We found a moderate positive correlation between CRP level and age (r=0.458, P=0.000); a weak positive correlation between PRL level and age was not statistically significant (r=0.201, P=0.093). A moderate positive correlation between CRP level and PRL level (r=0.461, P=0.03) was statistically significant. Conclusion: The current study implies that serum CRP levels might be an important indication of COVID-19 development and severity. A more extensive study with a larger sample size is needed to validate the significance of PRL in disease severity.
first_indexed 2024-03-09T01:37:36Z
format Article
id doaj.art-d695235da7174f46987fce593bf99623
institution Directory Open Access Journal
issn 2158-0510
2158-0529
language English
last_indexed 2024-03-09T01:37:36Z
publishDate 2023-12-01
publisher International Medical Research and Development Corporation
record_format Article
series International Journal of Biomedicine
spelling doaj.art-d695235da7174f46987fce593bf996232023-12-09T05:10:56ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292023-12-0113428629510.21103/Article13(4)_OA9The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAEAisha Abdulkrim Nur0Ahmed L. Osman1Praveen Kumar Kandakurti2Ayman H. Alfeel3Marwan Ismail4Asaad Ma. Babker5Abdelgdair A. Altoum6College of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAECollege of Health Sciences, Gulf Medical University, Ajman, UAEBackground: This study aimed to estimate the levels of CRP and PRL in SARS-CoV2 infection and their association with the severity of COVID-19 among patients in Ajman, UAE. Methods and Results: This cross-sectional study was conducted in Thumpay Hospital from 2020 to 2021. The study included 71 patients (55 males and 16 females) with positive SARS-CoV-2 test results. Nasal swab specimens were collected for the COVID-19 test on the day of admission or after one day of admission. COVID-19 diagnoses and severity levels were determined according to the New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China (2020). Serum samples were collected from the patients upon admission. The PRL level was determined using the immune chemiluminescent method by the DXI 800 Beckman Coulter analyzer. The CRP level was determined using the immunoturbidimetric method by the DXC 700 AU chemistry analyzer. Among 71 COVID-19 patients, the great majority were men 55(77.5%), 38(53.5%) being of Indian nationality. In this study, most participants (50.7%) had no history of chronic illnesses. In terms of COVID-19 severity, 24(33.8%) of patients had mild cases, 27(38.0%) had moderate cases, and 20(28.2%) had severe cases. Twenty (28.2%) patients were transferred to the ICU, and 19(26.8%) were intubated. The patients' average age was 47.58±13.63, CRP level - 74.30±71.46 mg/L, and PRL level - 205.1946±168.52 ng/mL. The mean CRP level was highest in severe cases, compared to mild and moderate cases, with a statistically significant difference between mild and severe groups (P=0.000) and mild and moderate groups (P=0.004). The mean PRL level was highest in severe cases compared to mild and moderate cases; however, the differences between the groups were not significant. CRP and PRL levels were greater in the ICU patients than non-ICU patients, with statistically significant differences only for CRP. We found a moderate positive correlation between CRP level and age (r=0.458, P=0.000); a weak positive correlation between PRL level and age was not statistically significant (r=0.201, P=0.093). A moderate positive correlation between CRP level and PRL level (r=0.461, P=0.03) was statistically significant. Conclusion: The current study implies that serum CRP levels might be an important indication of COVID-19 development and severity. A more extensive study with a larger sample size is needed to validate the significance of PRL in disease severity.http://www.ijbm.org/articles/i52/ijbm_13(4)_oa9.pdfcovid-19prolactinc-reactive protein
spellingShingle Aisha Abdulkrim Nur
Ahmed L. Osman
Praveen Kumar Kandakurti
Ayman H. Alfeel
Marwan Ismail
Asaad Ma. Babker
Abdelgdair A. Altoum
The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
International Journal of Biomedicine
covid-19
prolactin
c-reactive protein
title The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
title_full The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
title_fullStr The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
title_full_unstemmed The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
title_short The Association of Prolactin and CRP Biomarkers with the Severity of COVID-19 in Thumbay Hospital, Ajman, UAE
title_sort association of prolactin and crp biomarkers with the severity of covid 19 in thumbay hospital ajman uae
topic covid-19
prolactin
c-reactive protein
url http://www.ijbm.org/articles/i52/ijbm_13(4)_oa9.pdf
work_keys_str_mv AT aishaabdulkrimnur theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT ahmedlosman theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT praveenkumarkandakurti theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT aymanhalfeel theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT marwanismail theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT asaadmababker theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT abdelgdairaaltoum theassociationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT aishaabdulkrimnur associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT ahmedlosman associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT praveenkumarkandakurti associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT aymanhalfeel associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT marwanismail associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT asaadmababker associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae
AT abdelgdairaaltoum associationofprolactinandcrpbiomarkerswiththeseverityofcovid19inthumbayhospitalajmanuae